You are on page 1of 6

BIOCON LIMITED

Biocon Limited is a globally recognized as a innovation led organization that is enabling


access to high quality , advanced therapies for diseases that are chronic where medical
needs are largely unmet and treatment costs are high . They are driven by the belief that the
pharmaceuticals industry has a humanitarian responsibility to provide essential drugs to
patients who are in need and to do so with the power of innovation . In alignment with their
belief they developed and commercialized a differentiated portfolio of novel biologics ,
biosimilars and small molecule APIs in India and several key global markets as well as
generic formulations in the U.S. and Europe .
They are a leading player for biosimilars and APIs for statins , immunosuppressants and
other specialty molecules with customers in over 120 countries . Their subsidiary Biocon
biologics is engaged in developing high quality , affordable biosimilars aimed at expanding
patient access to a cutting edge class of therapies across the world .
It is uniquely positioned as a fully integrated pure play biosimilars organization globally .
They aspires to transform patient lives through innovative and inclusive healthcare solutions
. They have a large portfolio of biosimilars under global clinical development with three of
these commercialized in developed markets like EU, Australia , U.S. , Japan . It has a product
pipeline of 28 molecules , including 11 partnered with Mylan , several with Sandoz . They
were a leading global insulins player over 15 years of experience in addressing the needs of
diabetes patients , it has provided over 2 billion doses of recombinant human insulin (rh
insulin) worldwide . Through their subsidiary , Syngene , they offer high end , fully integrated
scientific research services that drive innovation , deliver greater efficiency and ensure value
creation for clients in the global life sciences sector .
Biocon is the only company from Asia to feature on the prestigious U.S. based Science
magazine’s annual Top global pharma and biotech employees list . They were ranked no 6 in
2019 , and have featured consistently on this list since their debut in 2012.
Their passion to impact global health that enabled it to touch millions of patients lives .
Their goal is to develop affordable blockbuster drugs with potential to benefit a billion
patients .

Vision
To enhance global healthcare through innovative and affordable biopharmaceuticals for
patients , partners and healthcare systems across the globe .
Mission
To be an integrated biotechnology enterprise of global distinction .
Essential to this mission is excellence in :

 Intellectual asset creation through discovery , research and development .


 State-of-the-art manufacturing capabilities
 Internationally benchmarked quality and regulatory systems
 New medical insight through disease specific clinical research
 Customer relationship through outstanding products and services
 Human resource development through training and mentoring , empowering
 Management of research and business partnerships
Values

 Integrity and Ethical Behaviour


 Performance driven work culture
 Value creation through innovation and differentiation
 Quality through compliance and best practices
 Collaboration , Team work and mutual respect
Corporate Social Responsibility
“All the wealth in the world cannot help one little Indian villages if the people are not
taught to help themselves”
- Swami Vivekananda
Biocon corporate social responsibility initiatives started in the year 2004 , are based on the
principle of making enduring impact through programs that promote social and economic
inclusion. CSR has been integral part of their business since inception . They are committed
to innovation, affordability and access to healthcare. In alignment with their commitment
and as a socially responsible organization. CSR focus areas health care , education , art and
culture , safety of women and children , gender equality , support for the differently abled ,
rural development . They contributed 2% of their profit towards CSR Activities .
Financial Highlights

You might also like